Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
- Glenwood Goss
- , Chun Ming Tsai
- , Frances A. Shepherd
- , Lyudmila Bazhenova
- , Jong Seok Lee
- , Gee Chen Chang
- , Lucio Crino
- , Miyako Satouchi
- , Quincy Chu
- , Toyoaki Hida
- , Ji Youn Han
- , Oscar Juan
- , Frank Dunphy
- , Makoto Nishio
- , Jin Hyoung Kang
- , Margarita Majem
- , Helen Mann
- , Mireille Cantarini
- , Serban Ghiorghiu
- , Tetsuya Mitsudomi
- University of Ottawa
- National Yang Ming Chiao Tung University
- Ontario Cancer Institute
- University of California at San Diego
- Seoul National University
- University of Perugia
- Hyogo Cancer Center
- University of Alberta
- Aichi Cancer Center Hospital and Research Institute
- National Cancer Center Korea
- Hospital Universitario La Fe
- Duke University
- Japanese Foundation for Cancer Research
- Hospital de La Santa Creu I Sant Pau
- AstraZeneca
- Kindai University
Research output: Contribution to journal › Article › peer-review
608
Scopus
citations